ClinicalTrials.govpublic full text
Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine
covid-19, covid, mab, antibody, vyd2311, liberty, invivyd, vaccine, sars-cov-2 monocloncal antibody, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870427
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.